Hypercalcemia of malignancy: Difference between revisions
No edit summary |
No edit summary |
||
Line 31: | Line 31: | ||
==See Also== | ==See Also== | ||
[[Hypercalcemia]] | *[[Hypercalcemia]] | ||
==Source== | ==Source== |
Revision as of 01:26, 23 October 2011
Background
- Causes:
- PTHrP release
- SCC (particularly of the head and neck), breast renal, endometrial cancer
- Local osteolysis
- Associated primarily with bone mets
- Multiple myeloma, lung, breast cancer
- Production of vitamin D analogues
- Lymphoma (Hodgkin)
- PTHrP release
Clinical Features
- See Hypercalcemia
Work-Up
- Chem10
- Ionized Ca
- CBC
- LFTs (alk phos, albumin)
- ECG
Treatment
- See Hypercalcemia
Disposition
- Ca <12
- Home with f/u if oncology concurs
- Ca>12
- Admit ward
- ECG changes
- Admit telemetry
See Also
Source
- EM Practice 3/10
- Tintinalli